Objective: To describe the spectrum of brain MRI findings in a cohort of individuals with dystroglycanopathies (DGs) and relate MRI results to function.
The dystroglycanopathies (DGs) are a group of autosomal recessive muscular dystrophies characterized by reduced or absent glycosylation of a-dystroglycan resulting from mutations in 1 of 18 currently known genes. Genotype-phenotype comparisons have proven difficult, as most genes are associated with a broad spectrum of phenotypes, though all affected individuals have muscular dystrophy. The most severe type is Walker-Warburg syndrome (WWS), which consists of congenital muscular dystrophy (CMD) with severe brain and eye malformations, minimal development, and short survival. 1 The least severe is adult-onset limb-girdle muscular dystrophy (LGMD) with slowly progressive muscle weakness, normal cognitive function, and normal brain MRI. 2 The first descriptions of brain malformations in DGs come from early reports of a novel pattern of brain and eye malformations associated with muscular dystrophy long before the genes were known. 1, [3] [4] [5] [6] [7] MRI abnormalities (particularly the severity of cortical dysgyria) were then correlated with the clinical CMD syndromes Fukuyama, muscle-eye-brain (MEB), WWS, and pure CMD. 8 The current clinical classification system includes 7 categories based on a combination of clinical and MRI characteristics. 9 In this study, we report a retrospective review of brain MRI studies from a cohort of individuals with DGs and compare imaging findings to motor and cognitive function. Our results define the spectrum of DGassociated imaging changes in one of the largest cohorts to date and provide imagingphenotype correlations that should improve recognition of DG-associated brain malformations and allow more accurate counseling regarding possible outcomes. METHODS 
Participants. All individuals enrolled in a DG
natural history study (clinicaltrials.gov NCT00313677) were included. Entry criteria for the natural history study included evidence of DG based on elevated creatine kinase, muscle pathology, documented mutations in one of the known genes, or abnormal glycosylation of a-dystroglycan in cultured fibroblasts. No exclusion criteria for the natural history study were defined. In the analysis reported here, we included only individuals with genetic testing supporting a diagnosis of DG: FKRP (60), FKTN (6), POMT1 (4), POMT2 (7), POMGNT1 (6), GMPPB (5), and ISPD (1).
Detailed clinical information including developmental milestones, comorbid conditions, and whether brain imaging had been done was systematically collected at entry into the study and updated annually. Individuals under age 1 were excluded from the description of best language and motor development. Seven individuals in this study have been reported previously. 10, 11 Brain MRIs were requested for our review with additional consent from participants. When the actual image was not available, reports were requested. Brain MRIs were done for clinical indications, not as part of the natural history study.
Standard protocol approvals, registrations, and patient consents. The University of Iowa institutional review board approved this study. Informed consent was obtained from all participants at enrollment. Consent to release medical information was obtained from participants to allow collection of outside MRI and reports.
MRI. All MRIs were reviewed by 2 reviewers, with (K.D.M.) or without (W.B.D.) knowledge of the genotype and phenotype, and findings were recorded systematically. When there was a discrepancy between reviewers, or between reviewers and radiology report, the scans were re-reviewed without knowledge of original report until consensus was reached. MRIs were separated into 3 groups based on the presence or absence of cortical malformation, cerebellar hypoplasia, and brainstem hypoplasia. Group 1 (most severe) has cortical, brainstem, and cerebellar malformations and includes the classic diagnoses of WWS (group 1A) and MEB disease (group 1B). Group 2 MRIs have both cortical and cerebellar malformations (group 2A) or cortical malformation alone (group 2B), with normal brainstem. Normal MRIs constitute group 3. Table 1 summarizes our classification and compares it to the clinical classification of Godfrey et al. 9 Cobblestone malformation (COB) refers to the severe cortical dysplasia that has been previously described in the DGs; it consists of an undersulcated and pebbled cerebral surface, irregular white-gray junction, and discontinuous, thin subcortical heterotopia. 12 Dysgyria refers to a more subtle abnormal gyral pattern that lacked sufficient specific features to designate it as COB or another known cortical malformation. Bowing describes a posterior concavity of the brainstem that is less severe than the kinked brainstem typical of WWS. Based on the child's estimated cognitive age, the Peabody Picture Vocabulary Test, Receptive/Expressive Emergent Language Test, or the Preschool Language Scale (PLS) were administered. Sometimes only portions of these protocols (e.g., auditory comprehension subtest of the PLS) were administered as tolerated by the child during the assessment. These evaluations identified 3 groups based on communication: severe impairment with little to no communication, intermediate impairment with receptive language considerably better than expressive, and normal. Poor speech production due to jaw position and posturing was not considered a language disorder.
Statistical analysis. The association of graded severity of MRI with ambulation status was tested using the Cochran-Armitage trend test. The Mantel-Haenszel x 2 test was used to examine the association of graded severity of MRI with degree of language abnormality. Both analyses were repeated excluding patients with mutations in FKRP. Significance was set at p # 0.05 for all assessments.
RESULTS We selected 89 individuals from the DG natural history study who met our enrollment criteria, including 53 male (60%) and 36 female (40%) participants. Brain MRIs were performed in 34 participants, and 25 of these were available for review. Of those with MRI reports/scans available, there were 22 male (65%) and 12 female (35%) participants. Reports Table 1 Comparison of the dystroglycanopathy classification system in the current article (image-based) vs that proposed by Godfrey et al. 9 Godfrey et al. 9 Image-based classification were reviewed for the remaining 9 participants. Age at the time of MRI ranged from 2 months to 45 years with an average of 6 years. Fifteen MRI scans and 4 MRI reports showed no abnormalities related to DG. One individual showed typical findings of a known diagnosis of multiple sclerosis and was included in this group. Ten MRI scans and 5 MRI reports were abnormal related to DG. Of these, 4 MRI scans and 3 MRI reports had severe malformation involving the brainstem (group 1B, figure 1, A malformation (n 5 4) or more subtle dysgyria (n 5 6), typically with an anterior more severe than posterior gradient. One individual had a predominantly temporal-occipital dysgyria (figure 2). Two individuals with subtle decreased sulcation of the frontal lobes were included in group 3 (figure e-1).
White matter abnormalities were seen in 5 individuals. The distribution was either diffuse (n 5 3, all in group 1B) or patchy (n 5 2, both in group 2A). Five individuals had ventricular dilatation ranging from moderate (n 5 3, all in group 1B) to mild (n 5 2, in groups 1B and 2A). Cerebellar hypoplasia, vermian or hemispheric, was the most common posterior fossa abnormality, observed in 9 individuals. Foliar dysplasia was documented in a single individual (individual 1), although it was likely present in all based on published studies. 13 Cerebellar cysts were present in 5 individuals graded as mild (n 5 1), moderate (n 5 2), or severe (n 5 2). Brainstem abnormalities were seen in the 4 group 1B participants, and included brainstem bowing (n 5 3), pontine hypoplasia (n 5 4), and enlarged tectum (n 5 3). Table 2 summarizes key clinical data in the whole cohort (n 5 89) in relation to the MRI findings (by review or report) and includes a subgroup of individuals (n 5 55) with no MRI report/scan to review. Two children in the first year of life were excluded from language and motor development analyses. Seven individuals have epilepsy, and all have abnormal brain imaging. Language development was abnormal While most individuals achieved walking regardless of MRI abnormality, maximal motor milestones in the nonambulatory group were variable and generally related to degree of MRI abnormality. Of those in group 1, 1 (17%) was unable to lift the head from prone, 2 (33%) achieved rolling, and 1 (17%) could sit unassisted. One individual (13%) in group 2 achieved rolling, 1 (13%) could sit unassisted, and 4 (50%) could sit and scoot. One individual (5%) in group 3 could stand, but not walk. Of those with no MRI report/scan to review, 1 (2%) could lift the head from prone and 1 (2%) could sit unassisted. The individual with the most substantial motor deficits in this group had brain abnormalities described by CT report. Acquisition of independent ambulation occurred less frequently in those with severe brain imaging (Cochran Armitage p 5 0.0007), and this relationship remained significant after excluding participants with FKRP mutations (p 5 0.036).
DISCUSSION In our cohort of 89 individuals with DG, 34 (38%) had brain MRI or reports. Of those with brain MRI, 15 (44%) had abnormal brain imaging attributable to hypoglycosylation of a-dystroglycan. The most common features include cobblestone cortical malformation or less specific (but still DGassociated) dysgyria, typically with an anterior to posterior gradient, and cerebellar hypoplasia. Not surprisingly, abnormal brain imaging was associated with epilepsy and with more severe deficits in motor and language function. Severe language deficits were seen in 11 of 14 individuals with any brain malformation. Motor function was also more severe in this group, but with substantial variability. Typical brain MRI abnormalities can suggest a DG or support the diagnosis when a genetic variant of unknown significance is found, 14 leading to a recommendation to perform brain MRIs in suspected cases of CMD. 15 Cobblestone cortical malformation (known as cobblestone lissencephaly for the severe end of the spectrum) is the hallmark brain imaging finding in individuals with DG. Although we differentiate between COB and dysgyria in this study, these are certain to represent different levels of severity of the same underlying developmental pathology. In all syndromes other than WWS, the cortical malformation predominantly affects the frontal lobes, resulting in an anterior-posterior gradient, although malformations can also extend into the temporal and parietal lobes. 9, 16, 17 One individual in our cohort with mutations in POMGnT1 had COB that was more severe in the temporal-occipital lobes than the frontal lobes, a rare pattern with DGs. This has been reported in individuals with Fukuyama CMD and in other individuals with FKTN or POMT1 mutations, however.
17-20 COB predominantly affecting the occipital and parietal lobes is also seen in individuals harboring mutations of laminins, including LAMA2 (with CMD), LAMB1, and LAMC3 (without CMD). [21] [22] [23] Cerebellar abnormalities (hypoplasia, foliar dysplasia, cysts) are common in individuals with DG, usually associated with cortical and brainstem malformations, and have rarely been reported without other brain malformations, although these reports were partly based on older, lower-resolution scanners. 9, 24, 25 In the current study, all individuals with cerebellar abnormalities had evidence of dysgyria, though some were mild. Thus, scrutiny of MRI scans or reevaluation using higher-resolution scanners in previously reported individuals may unveil mild cortical dysgyria. These individuals with predominantly cerebellar involvement would therefore be categorized by our system as group 2A.
Posterior concavity of the brainstem, referred to here as bowing, has been reported in individuals with severe brain abnormalities 17 and, in the current study, was noted in only the 3 most abnormal MRI scans. Previous reports have speculated that the infratentorial structures are more vulnerable to the underlying disease process, 17, 24 though preferential infratentorial involvement was not noted in our cohort.
The structural abnormalities evident on brain MRI reflect the role of a-dystroglycan in development. Glycosylated a-dystroglycan is expressed on the endfeet of glial cells and provides a link between glial cells in the developing brain and the pial basement membrane. Abnormal glycosylation of a-dystroglycan leads to loss of this linkage, gaps in the basement membrane, and overmigration of neuronal cells leading to cobblestone lissencephaly. 26 Recent work has shown that abnormal glycosylation of a-dystroglycan in Bergman glial cells in the cerebellum similarly results in discontinuity of the glial limitans and cerebellar heterotopia. 27 Mice with reduced or absent DG have developmental brain malformations of variable severity, similar to the spectrum seen in humans. 28, 29 Due to the phenotypic variability associated with each gene, several approaches have been used to classify the DGs based on brain imaging or pathology. The MRI-based categories used in the present study differ slightly from those used by others. The current commonly used classification system includes 7 categories, based on a combination of imaging and clinical features, and capturing the spectrum of severity. 9 A study of the pathologic brain and eye findings in a cohort of fetal cases demonstrated 3 distinct subtypes of COB within the severe end of the spectrum. 13 Due to the small number of severely affected brains in this study, we collapsed the most severe categories from previous studies into a single group.
Understanding the range of motor function and language function seen with normal and abnormal MRI patterns allows more accurate family counseling. Cognitive impairment is frequent in individuals with CMD due to DG; one study reported that 37 of 43 (86%) participants with CMD and reduced a-DG staining on muscle biopsy had cognitive impairment. 30 The range of development in relation to MRI seen in our cohort is summarized in table 3. Our results and those of other series show an expected relationship between severity of brain malformation and intellectual function. 31 Among our participants with abnormal brain imaging, 100% had cognitive impairment. Those with a combination of cortical and posterior fossa abnormalities uniformly had severe language impairment.
Among those with normal brain MRIs, language and motor disabilities were seen in individuals with mutations in POMGnT1, POMT2, and FKRP. Abnormal development with normal MRI has previously been reported, most often associated with mutations in POMT1 and POMT2, 9,30,31 but also with DAG1 mutations 32, 33 and, less frequently, with FKRP mutations. 16 In the current study, abnormal brain MRI strongly predicts impaired language development, but normal MRI does not accurately predict normal language. Of note, all participants with normal development had normal brain MRIs, suggesting no added benefit of performing brain MRIs in developmentally normal individuals.
Epilepsy has been reported in individuals with DG and has been attributed to migration defects during neuronal development. 34 Consistent with this, 57% of our participants with the most abnormal MRIs (group 1) have epilepsy, compared to none with 
Values are n (%). a One individual with CT showing marked ventricular dilation, periventricular white matter changes, brainstem hypoplasia, and cerebellar hypoplasia and no MRI available.
normal MRI. The 6 individuals with epilepsy for whom we reviewed MRIs all had cortical abnormalities indicative of migration defects. A single individual with epilepsy had no MRI report or scan available to review and had abnormalities consistent with group 1B based on CT report. Motor development was more variably related to brain structure, and 85% of our cohort achieved independent ambulation. A study of participants with FKRP mutations suggested motor development correlated better with cognitive impairment than MRI abnormalities. 16 In our cohort, motor development was more abnormal in those with language impairment and abnormal MRIs. Neither could accurately predict motor development, however. Of note, independent ambulation was achieved in 2 individuals with MRIs in group 1 and severe language impairment.
In comparing our interpretation of the MRI scans to those in the original radiology report, there was general agreement on the severity of brain involvement. It was apparent we were more likely to report dysgyria whereas the original report was more likely to report white matter signal abnormalities in isolation.
A limitation of our study was a lack of individuals with a typical Walker-Warburg phenotype. Other limitations relate to the fact that this was a retrospective review of MRIs done for clinical indications. Thus, if individuals with DG with normal brain functioning often have abnormal imaging, our study will overestimate the probability of disability based on MRI. Against this is the fact that several MRIs were done in adults with LGMD for indications unrelated to DG (e.g., headache), and we did not see subtle abnormalities. As MRIs were done with different techniques, images reviewed were of variable quality.
Developmental abnormalities of the brain such as cobblestone lissencephaly, cerebellar cysts, pontine hypoplasia, and brainstem bowing suggest a DG, especially in conjunction with elevated CK. Presence of structural brain abnormalities is significantly related to abnormal function, as expected. However, in individual cases, people may learn to walk despite significant abnormalities in brain imaging, and normal imaging does not exclude abnormal development, particularly of language. These findings will assist clinicians in counseling individuals with DG and their families.
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